In sub-Saharan Africa, cataracts blind approximately five million people. Each of them could regain their sight in less than half an hour, for a cost of less than fifty dollars in equipment. This gap between what is technically possible and what exists on the ground is one of the most documented and least resolved health injustices in the world.

Cataract surgery is, according to studies published in The Lancet Global Health and by the IAPB (International Agency for the Prevention of Blindness), the medical intervention with the best cost-benefit ratio in all of medicine. Twenty minutes. One trained surgeon, an intraocular lens, an equipped operating room. The patient who enters blind leaves with restored vision in more than 90% of cases when conditions are met. And yet, sub-Saharan Africa accounts for a growing share of untreated cases, not for lack of equipment, but for lack of surgical hands.

Key Points

  • Cataracts cause approximately 45% of global blindness, with a large share in sub-Saharan Africa, according to the IAPB.
  • Surgery costs less than 50 dollars in equipment thanks to Indian production of low-cost intraocular lenses.
  • Sub-Saharan Africa has fewer than 0.5 ophthalmologists per 100,000 inhabitants on average, compared to more than 7 in Europe, according to the WHO.
  • Accelerated training programs and task delegation in Rwanda and Kenya have increased the volume of operations tenfold over periods of three to five years.
  • Without acceleration of surgical training, the number of people blinded by cataracts in the region is expected to double by 2050, due to the combined effect of demographic aging and persistent insufficient supply of care.

When Equipment Cost is No Longer the Obstacle

For decades, the cost of intraocular lenses represented the main barrier to cataract treatment in low and middle-income countries. In the 1990s, a quality lens cost between 100 and 200 dollars — more than the monthly income of a household in most sub-Saharan African countries.

The transformation came from India. Aurolab, a laboratory founded in 1992 by the Aravind Eye Care hospital system in Madurai, began producing intraocular lenses at large scale for a fraction of the price of Western manufacturers. In 2025, Aurolab exports to more than 130 countries at less than 3 dollars per lens. This is not an industrial accident: it is the result of an explicit strategy of mass production anchored in a social mission, which has progressively forced other manufacturers to align.

This price collapse transformed the economic equation of treatment. The cost-benefit ratio of cataract surgery, calculated in quality-adjusted life years (QALY), now rivals childhood vaccination — which, in the hierarchy of global public health, is an extraordinary comparison. A Cochrane Collaboration study cited in The Lancet estimated that each dollar invested in cataract surgery in sub-Saharan Africa generates an economic return of 35 to 55 dollars, primarily through the restoration of earning capacity for working-age patients.

This return is not merely accounting. In the vast majority of cases treated in African studies, patients are women between 50 and 70 years old: grandmothers who care for children while parents work, farmers whose vision determines household food security. Restoring sight to this population means restoring productivity to an entire chain of invisible economic dependencies.

A Surgical Desert That Is Not Inevitable

If equipment is no longer the main obstacle, why do the five million people blinded by cataracts in sub-Saharan Africa remain untreated?

The answer lies in a brutal figure. According to WHO and IAPB data, sub-Saharan Africa has approximately 0.4 ophthalmologists per 100,000 inhabitants. The European level is 7 per 100,000. In the United States, 8. This density does not merely reflect a lack of resources: it is the product of a medical training system inherited from colonial structures, calibrated to produce specialists according to a Western model of ten to fifteen years of training, in contexts where massive rural demand never meets the patient flows in urban centers needed to justify investments.

The consequence is arithmetic. Even at full capacity, an ophthalmologist performs on average between 600 and 1,000 cataract operations per year. In sub-Saharan Africa, several thousand additional surgeons would be needed to treat existing cases within three to five years. Classical training takes decades to produce them.

But this desert is not structurally irreparable. And this is where experiments conducted in Rwanda and Kenya since the early 2010s become relevant.

What Rwanda and Kenya Have Proven

The task delegation model — assigning to non-medical personnel acts previously reserved for ophthalmologists — was born in African ophthalmology from practical necessity, not theory. In the 2000s, several programs supported by the IAPB and NGOs such as Fred Hollows Foundation began training ophthalmic technicians, specialized nurses, and clinical officers in cataract surgery according to standardized protocols. These personnel receive training lasting twelve to eighteen months, supervised by surgeons, with strict criteria for supervision and accreditation.

In Kenya, the training program for ophthalmic clinical officers (OCO) gradually expanded the procedures authorized for these paramedical personnel. According to data published by the IAPB, certain Kenyan districts increased their cataract surgery rate eightfold to tenfold between 2010 and 2022, primarily through this delegation. The rates of postoperative complications measured in these programs are comparable to those of specialized centers, provided that patient selection protocols are respected.

In Rwanda, the government integrated this approach into its national eye health plan. The country trained a cohort of ophthalmic nurses capable of performing the least complex operations, freeing ophthalmologists for complicated cases, training, and supervision. In ten years, Rwanda’s cataract surgery rate increased sevenfold, according to data from the Rwandan Ministry of Health and IAPB reports.

These results do not mean that task delegation is without limits. Complicated cases — hypermatured cataracts, ocular comorbidities, children — require ophthalmology expertise. Supervision remains necessary. And the systems that worked in Rwanda and Kenya both benefited from a strong institutional framework: a ministry of health that sets standards, monitoring of results, and capacity to identify and correct problems. This is not a recipe that can be exported without conditions. As illustrated by Mexican experience in other sectors, competitive or operational advantage is worthless without the institutions that anchor it.

The Race Against the Continent’s Aging

The issue is not static. Sub-Saharan Africa is aging. Not at the pace of Europe or Japan, but at a speed that will radically transform the structure of its healthcare demand. Cataracts are a disease of aging: their prevalence increases sharply after age 60, and in populations exposed to high solar radiation, they occur on average ten to fifteen years earlier than in Europe.

According to IAPB projections based on United Nations demographic data, if the cataract surgery rate in sub-Saharan Africa remains at its current level, the number of people blinded by cataracts is expected to double between now and 2050. The demographic variable — the growth of the population over 50 years old — alone is sufficient to produce this doubling even without any deterioration of existing healthcare systems. This is not a pessimistic scenario: it is the default trajectory, the one that materializes if nothing changes.

This doubling would have effects that go beyond health. An economically active population that loses its sight in its fifties and sixties exits the labor market, increases the burden on following generations, and reduces households’ capacity to invest in children’s education. In African economies where family farming remains central, the blindness of a parent often means a child’s interrupted schooling. The arc of loss is long.

The turning point could come from simultaneous acceleration on two axes: accelerated training via proven delegation programs, and large-scale public funding of operations. The total cost of treating Africa’s surgical backlog in cataracts is estimated by the IAPB at several billion dollars — a figure that seems considerable until compared to the economic losses generated by untreated blindness, calculated by the World Bank in terms of lost GDP.

What Local Experiments Have Not Yet Resolved

Despite the successes of Rwanda and Kenya, the question of scaling up remains open. These programs worked in specific contexts: relatively centralized health systems, strong political will, partnerships with NGOs capable of providing funding and technical supervision. They have not yet been replicated with the same success in countries where healthcare infrastructure is less developed or governance more fragmented.

The other unknown is financial sustainability. Much of the cataract surgery performed in low-income countries is financed by international organizations: Fred Hollows Foundation, Sightsavers, Orbis International, and national programs supported by donors such as the United Kingdom (FCDO) or the Gates Foundation. Such funding is inherently uncertain. When it withdraws, operation volumes collapse. The challenge of sustainability — building systems that function without permanent injections of external funding — remains unresolved.

A more robust economic model would involve integrating cataract surgery into essential care packages guaranteed by states, financed through national health budgets or via universal health insurance systems currently being deployed in several African countries. Ethiopia, which is progressively developing its universal health coverage under budget constraints, illustrates the tension between health ambition and fiscal capacity — a tension the country negotiates with international aid that both constrains and enables.

This is not a dead end. The cost per operation in a well-organized large-scale system falls below 50 dollars. Even a modest universal health insurance, or targeted public funding, can absorb this cost. The question is not whether it is affordable: it is whether political priorities align quickly enough for scaling to happen before the demographic wave makes the problem structurally uncontrollable.

Time Matters More Than Equipment

The history of cataract surgery in sub-Saharan Africa is one of a bottleneck that has shifted. Equipment cost has been solved. The technique is mastered. The proof of concept for accelerated training programs exists. What is missing is not knowledge of the solution: it is execution pace.

Each year of delay produces cohorts of patients who would not be blind in a better-organized system. And each blind patient represents a chain of economic and social consequences that propagate over a decade. The math is simple, even if the politics is not.

The task delegation programs proven in Rwanda and Kenya do not require technological breakthroughs. They require institutional will, stable funding, and the political decision to recognize that trained nurses can restore sight to patients whom no conventional ophthalmologist will ever reach in rural areas by 2050. It is a choice of organization, not an unsolved medical equation.

The question that remains open is which governments, which donors, and which African regional coalitions will decide to treat cataracts as what they already are in the data: the preventable disease with the best cost-benefit ratio on the continent, whose silent epidemic grows as the age pyramid widens at its base.

Sources

  1. The Lancet Global Health — https://www.thelancet.com/journals/langlo/home
  2. IAPB (International Agency for the Prevention of Blindness) — World Report on Vision and regional data: https://www.iapb.org
  3. World Health Organization — World Report on Vision (WHO, 2019): https://www.who.int/publications/i/item/9789241516570
  4. Aurolab (Aravind Eye Care system): https://www.aurolab.com
  5. Fred Hollows Foundation — sub-Saharan Africa programs: https://www.hollows.org
  6. Sightsavers — cataract operations data Africa: https://www.sightsavers.org